Cheap and Routine

Jay Flatley, the CEO of Illumina, told the UK's Times that by 2019, the genome sequencing of newborns will be routine and that in three to four years a genome sequence should be available for less than $1,000. "The limitations are sociological; when and where people think it can be applied, the concerns people have about misinformation and the background ethics questions," Flatley says.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.